Assessment on interactive prospectives of nanoplastics with plasma proteins and the toxicological impacts of virgin, coronated and environmentally released-nanoplastics.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 06 2019
Historique:
received: 07 03 2019
accepted: 31 05 2019
entrez: 22 6 2019
pubmed: 22 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

Recently, the concerns about micro- and nano-plastics (NPs) toxicity have been increasing constantly, however the investigations are quiet meager. The present study provides evidences on the toxicological prospectives of virgin-, coronated- and isolated-NPs on human blood cells and Allium cepa root tip, respectively. Several plasma proteins displayed strong affinity towards NPs and produced multi-layered corona of 13 nm to 600 nm size. The coronated-NPs often attracted each other via non-specific protein-protein attraction which subsequently induced protein-induced coalescence in NPs. In the protein point of view, the interaction caused conformational changes and denaturation of protein thereby turned it as bio-incompatible. The coronated-NPs with increased protein confirmation changes caused higher genotoxic and cytotoxic effect in human blood cells than the virgin-NPs. On the other hand, virgin-NPs and the NPs isolated from facial scrubs hindered the root growth and caused chromosome aberration (ring formation, C-mitotic and chromosomal breaks, etc.) in root of Allium cepa. At the outset, the present study highlights the urgent need of scrutinization and regulation of NPs use in medical applications and pre-requisition of additional studies for assessing the bio-accumulation and bio-magnification of NPs.

Identifiants

pubmed: 31222081
doi: 10.1038/s41598-019-45139-6
pii: 10.1038/s41598-019-45139-6
pmc: PMC6586940
doi:

Substances chimiques

Blood Proteins 0
Mutagens 0
Plastics 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8860

Références

Annu Rev Biophys Bioeng. 1984;13:105-24
pubmed: 6378065
Environ Sci Technol. 2016 Apr 5;50(7):4037-44
pubmed: 26963589
J Biomol Struct Dyn. 2006 Dec;24(3):277-83
pubmed: 17054386
Chemosphere. 2019 Jan;215:74-81
pubmed: 30312919
Nanotoxicology. 2011 Mar;5(1):12-29
pubmed: 21417685
Environ Toxicol. 2011 Apr;26(2):146-52
pubmed: 19760615
Science. 2014 Jul 11;345(6193):144-5
pubmed: 25013051
Environ Pollut. 2016 Dec;219:201-209
pubmed: 27814536
Nano Lett. 2009 Feb;9(2):666-71
pubmed: 19199758
Sci Rep. 2017 Apr 24;7:46687
pubmed: 28436478
J Phys Chem B. 2008 Dec 25;112(51):16793-801
pubmed: 19367911
Semin Immunol. 2017 Dec;34:52-60
pubmed: 29066063
J Environ Pathol Toxicol Oncol. 2002;21(1):57-61
pubmed: 11934013
Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):801-10
pubmed: 8896891
Langmuir. 2009 Oct 6;25(19):11686-91
pubmed: 19788221
Environ Pollut. 2015 Mar;198:211-22
pubmed: 25637744
Biomaterials. 2011 Nov;32(32):8291-303
pubmed: 21810539
Angew Chem Int Ed Engl. 2016 Jul 25;55(31):8806-15
pubmed: 27303916
Environ Sci Technol. 2016 Mar 1;50(5):2685-91
pubmed: 26852875
Sci Rep. 2016 May 05;6:25518
pubmed: 27145858
Mar Environ Res. 2014 Oct;101:29-37
pubmed: 25164019
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
pubmed: 18809927
Aquat Toxicol. 2018 Jul;200:28-36
pubmed: 29709883
J Nanobiotechnology. 2013 Jul 19;11:26
pubmed: 23870291
Int J Nanomedicine. 2017 Apr 18;12:3137-3151
pubmed: 28458536
Folia Histochem Cytobiol. 1990;28(1-2):79-95
pubmed: 2097185
Bioconjug Chem. 2017 Jan 18;28(1):88-97
pubmed: 27997136
Toxicol Sci. 2004 Sep;81(1):121-32
pubmed: 15178808
J Genet Eng Biotechnol. 2018 Dec;16(2):519-526
pubmed: 30733769
J Biophotonics. 2012 May;5(5-6):458-68
pubmed: 22389316
PLoS One. 2016 Mar 22;11(3):e0152074
pubmed: 27003833
Environ Sci Technol. 2016 Apr 5;50(7):4054-60
pubmed: 26950772
Environ Sci Technol. 2016 Aug 16;50(16):8849-57
pubmed: 27438693
Mutat Res. 1998 Jul 8;415(1-2):47-57
pubmed: 9711261
Environ Pollut. 2016 May;212:251-256
pubmed: 26851981
Environ Pollut. 2017 Jan;220(Pt A):495-503
pubmed: 27745914
Nanoscale. 2011 May;3(5):2028-35
pubmed: 21409242
Curr Biol. 2013 Dec 2;23(23):R1031-3
pubmed: 24309274
Sci Rep. 2017 Jun 1;7(1):2673
pubmed: 28572662
Food Chem Toxicol. 2002 Jan;40(1):65-75
pubmed: 11731037
Blood. 1980 Jan;55(1):156-9
pubmed: 7350935
Toxicology. 2002 Feb 28;171(2-3):175-86
pubmed: 11836023
Ecotoxicol Environ Saf. 2016 Jan;123:18-25
pubmed: 26422775
Adv Protein Chem. 1986;38:181-364
pubmed: 3541539
Mar Pollut Bull. 2013 Dec 15;77(1-2):220-6
pubmed: 24449923
Sci Total Environ. 2016 Apr 15;550:1110-1115
pubmed: 26874248
Sci Total Environ. 2017 Dec 31;609:1312-1321
pubmed: 28793400
Environ Sci Technol. 2012 Oct 16;46(20):11327-35
pubmed: 22963286
N Engl J Med. 2010 Dec 16;363(25):2434-43
pubmed: 21158659
Sci Adv. 2017 Jul 19;3(7):e1700782
pubmed: 28776036
Langmuir. 2012 Jun 19;28(24):9113-26
pubmed: 22439664
Nat Rev Cancer. 2009 Nov;9(11):842; author reply 842
pubmed: 19816457
ACS Nano. 2011 Sep 27;5(9):7155-67
pubmed: 21866933
Gene. 1995 Apr 14;156(1):27-31
pubmed: 7737512
Food Addit Contam. 2000 Dec;17(12):1037-45
pubmed: 11271838
Environ Sci Technol. 2013 Oct 1;47(19):11278-83
pubmed: 23988225
Environ Mol Mutagen. 2000;35(3):206-21
pubmed: 10737956
Mol Biosyst. 2015 Feb;11(2):454-62
pubmed: 25409650
Biomater Sci. 2014 Sep 29;2(9):1210-1221
pubmed: 32481892
Toxicol In Vitro. 2016 Mar;31:126-36
pubmed: 26585375
Curr Biol. 2013 Dec 2;23(23):2388-92
pubmed: 24309271
Environ Sci Technol. 2014 Oct 21;48(20):12302-11
pubmed: 25260196
Environ Toxicol Chem. 2016 Dec;35(12):3093-3100
pubmed: 27207313
Biomacromolecules. 2010 Mar 8;11(3):748-53
pubmed: 20166675
J Am Chem Soc. 2010 Apr 7;132(13):4834-42
pubmed: 20230032
Mutat Res. 1999 Jul 16;428(1-2):255-69
pubmed: 10517998
Environ Sci Technol. 2011 Nov 1;45(21):9175-9
pubmed: 21894925

Auteurs

Ponnusamy Manogaran Gopinath (PM)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Vinayagam Saranya (V)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Shanmugam Vijayakumar (S)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Mohan Mythili Meera (M)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Sharma Ruprekha (S)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Reshamwala Kunal (R)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Agarwal Pranay (A)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

John Thomas (J)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Amitava Mukherjee (A)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India.

Natarajan Chandrasekaran (N)

Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632014, TN, India. nchandrasekaran@vit.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH